BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 30328212)

  • 21. Serum Proteomic Variability Associated with Clinical Phenotype in Familial Transthyretin Amyloidosis (ATTRm).
    Chan GG; Koch CM; Connors LH
    J Proteome Res; 2017 Nov; 16(11):4104-4112. PubMed ID: 28922609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Native T1 and Extracellular Volume in Transthyretin Amyloidosis.
    Martinez-Naharro A; Kotecha T; Norrington K; Boldrini M; Rezk T; Quarta C; Treibel TA; Whelan CJ; Knight DS; Kellman P; Ruberg FL; Gillmore JD; Moon JC; Hawkins PN; Fontana M
    JACC Cardiovasc Imaging; 2019 May; 12(5):810-819. PubMed ID: 29550324
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carpal tunnel syndrome: a common initial symptom of systemic wild-type ATTR (ATTRwt) amyloidosis.
    Nakagawa M; Sekijima Y; Yazaki M; Tojo K; Yoshinaga T; Doden T; Koyama J; Yanagisawa S; Ikeda S
    Amyloid; 2016; 23(1):58-63. PubMed ID: 26852880
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A simple screening test for variant transthyretins associated with familial transthyretin amyloidosis using isoelectric focusing.
    Connors LH; Ericsson T; Skare J; Jones LA; Lewis WD; Skinner M
    Biochim Biophys Acta; 1998 Sep; 1407(3):185-92. PubMed ID: 9748569
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Established and candidate transthyretin amyloidosis variants identified in the Saudi population by data mining.
    Abouelhoda M; Mohty D; Alayary I; Meyer BF; Arold ST; Fadel BM; Monies D
    Hum Genomics; 2021 Aug; 15(1):52. PubMed ID: 34380564
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Late onset cardiomyopathy as presenting sign of ATTR A45G amyloidosis caused by a novel TTR mutation (p.A65G).
    Klaassen SHC; Lemmink HH; Bijzet J; Glaudemans AWJM; Bos R; Plattel W; van den Berg MP; Slart RHJA; Nienhuis HLA; van Veldhuisen DJ; Hazenberg BPC
    Cardiovasc Pathol; 2017; 29():19-22. PubMed ID: 28460244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiac amyloidosis: a review and report of a new transthyretin (prealbumin) variant.
    Hesse A; Altland K; Linke RP; Almeida MR; Saraiva MJ; Steinmetz A; Maisch B
    Br Heart J; 1993 Aug; 70(2):111-5. PubMed ID: 8038017
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transthyretin Cardiac Amyloidosis.
    Mankad AK; Shah KB
    Curr Cardiol Rep; 2017 Aug; 19(10):97. PubMed ID: 28840452
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidemiology of variant transthyretin amyloidosis at a reference center in Argentina.
    Saez MS; Aguirre MA; Pérez de Arenaza D; Sorroche P; Nucifora E; Posadas Martinez ML
    Mol Genet Genomic Med; 2021 Nov; 9(11):e1812. PubMed ID: 34668655
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnosis and therapeutic approaches to transthyretin amyloidosis.
    Ando Y; Ueda M
    Curr Med Chem; 2012; 19(15):2312-23. PubMed ID: 22471980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and Genetic Evaluation of People with or at Risk of Hereditary ATTR Amyloidosis: An Expert Opinion and Consensus on Best Practice in Ireland and the UK.
    Gillmore JD; Reilly MM; Coats CJ; Cooper R; Cox H; Coyne MRE; Green AJ; McGowan R; Moody WE; Hawkins PN
    Adv Ther; 2022 Jun; 39(6):2292-2301. PubMed ID: 35419651
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic and clinical characteristics of hereditary transthyretin amyloidosis in endemic and non-endemic areas: experience from a single-referral center in Japan.
    Yamashita T; Ueda M; Misumi Y; Masuda T; Nomura T; Tasaki M; Takamatsu K; Sasada K; Obayashi K; Matsui H; Ando Y
    J Neurol; 2018 Jan; 265(1):134-140. PubMed ID: 29177547
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sporadic Cardiac Amyloidosis by Amyloidogenic Transthyretin V122I Variant.
    Nehashi T; Oikawa M; Amami K; Kanno Y; Yokokawa T; Misaka T; Yamada S; Kunii H; Nakazato K; Ishida T; Takeishi Y
    Int Heart J; 2019 Nov; 60(6):1441-1443. PubMed ID: 31666456
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estimating the Prevalence of Transthyretin Amyloid Cardiomyopathy in a Large In-Hospital Database in Japan.
    Winburn I; Ishii T; Sumikawa T; Togo K; Yasunaga H
    Cardiol Ther; 2019 Dec; 8(2):297-316. PubMed ID: 31376091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and apparative investigation of large and small nerve fiber impairment in mixed cohort of ATTR-amyloidosis: impact on patient management and new insights in wild-type.
    Papagianni A; Ihne S; Zeller D; Morbach C; Üçeyler N; Sommer C
    Amyloid; 2022 Mar; 29(1):14-22. PubMed ID: 34632904
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of Low Plasma Transthyretin Concentration With Risk of Heart Failure in the General Population.
    Greve AM; Christoffersen M; Frikke-Schmidt R; Nordestgaard BG; Tybjærg-Hansen A
    JAMA Cardiol; 2021 Mar; 6(3):258-266. PubMed ID: 33237279
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tafamidis: a selective transthyretin stabilizer to treat wild-type ATTR amyloidosis and hereditary ATTR amyloidosis with cardiomyopathy.
    Paton DM
    Drugs Today (Barc); 2019 Dec; 55(12):727-734. PubMed ID: 31942875
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A rare variant in the TTR gene (p.E112K) is associated with systemic amyloidosis and a new symptom - skin hyperemia in response to ethanol intake: family segregation analysis, literature review, and a clinical case. Case report].
    Chumakova OS; Nasonova SN; Frolova YV; Stepanova EA; Mershina EA; Sinitsyn VE; Zateyshchikov DA; Zhirov IV
    Ter Arkh; 2023 May; 95(4):335-340. PubMed ID: 38158982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnosis of genetic amyloidosis through the analysis of transthyretin gene mutation using high-resolution melting.
    Lahuerta C; Menao S; Gracia-Gutierrez A; Bueno-Juana E; Guillén N; Sorribas V; Gracia AA; Aibar MA
    Int J Cardiol; 2020 Feb; 301():220-225. PubMed ID: 31740141
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A 15-year consolidated overview of data in over 6000 patients from the Transthyretin Amyloidosis Outcomes Survey (THAOS).
    Gentile L; Coelho T; Dispenzieri A; Conceição I; Waddington-Cruz M; Kristen A; Wixner J; Diemberger I; Gonzalez-Moreno J; Cariou E; Maurer MS; Planté-Bordeneuve V; Garcia-Pavia P; Tournev I; Gonzalez-Costello J; Duarte AG; Grogan M; Mazzeo A; Chapman D; Gupta P; Glass O; Amass L;
    Orphanet J Rare Dis; 2023 Nov; 18(1):350. PubMed ID: 37946256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.